(1) (a) The regulator for each licensed health-care provider, in consultation with the center for research into substance use disorder prevention, treatment, and recovery support strategies created in section 27-80-118, shall promulgate rules that require each licensed health-care provider, as a condition of renewing, reactivating, or reinstating a license on or after October 1, 2022, to complete up to four credit hours of training per licensing cycle in order to demonstrate competency regarding: (I) Best practices for opioid prescribing, according to the most recent version of the division’s guidelines for the safe prescribing and dispensing of opioids; (II) The potential harm of inappropriately limiting prescriptions to chronic pain patients; (III) Best practices for prescribing benzodiazepines; (IV) Recognition of substance use disorders; (V) Referral of patients with substance use disorders for treatment; and (VI) The use of the electronic prescription drug monitoring program created in part 4 of article 280 of this title 12. (b) The rules promulgated by each regulator shall exempt a licensed health-care provider who: (I) Maintains a national board certification that requires equivalent substance use prevention training; or (II) Attests to the regulator that the health-care provider does not prescribe opioids.
(a) The regulator for each licensed health-care provider, in consultation with the center for research into substance use disorder prevention, treatment, and recovery support strategies created in section 27-80-118, shall promulgate rules that require each licensed health-care provider, as a condition of renewing, reactivating, or reinstating a license on or after October 1, 2022, to complete up to four credit hours of training per licensing cycle in order to demonstrate competency regarding: (I) Best practices for opioid prescribing, according to the most recent version of the division’s guidelines for the safe prescribing and dispensing of opioids; (II) The potential harm of inappropriately limiting prescriptions to chronic pain patients; (III) Best practices for prescribing benzodiazepines; (IV) Recognition of substance use disorders; (V) Referral of patients with substance use disorders for treatment; and (VI) The use of the electronic prescription drug monitoring program created in part 4 of article 280 of this title 12.
(I) Best practices for opioid prescribing, according to the most recent version of the division’s guidelines for the safe prescribing and dispensing of opioids;
(II) The potential harm of inappropriately limiting prescriptions to chronic pain patients;
(III) Best practices for prescribing benzodiazepines;
(IV) Recognition of substance use disorders;
(V) Referral of patients with substance use disorders for treatment; and
(VI) The use of the electronic prescription drug monitoring program created in part 4 of article 280 of this title 12.
(b) The rules promulgated by each regulator shall exempt a licensed health-care provider who: (I) Maintains a national board certification that requires equivalent substance use prevention training; or (II) Attests to the regulator that the health-care provider does not prescribe opioids.
(I) Maintains a national board certification that requires equivalent substance use prevention training; or
(II) Attests to the regulator that the health-care provider does not prescribe opioids.
(2) For the purposes of this section, “licensed health-care provider” includes any of the following providers who are licensed pursuant to this title 12: (a) A physician; (b) A physician assistant; (c) A podiatrist; (d) A dentist; (e) An advanced practice registered nurse or certified midwife with prescriptive authority; (f) An optometrist; and (g) A veterinarian.
(a) A physician;
(b) A physician assistant;
(c) A podiatrist;
(d) A dentist;
(e) An advanced practice registered nurse or certified midwife with prescriptive authority;
(f) An optometrist; and
(g) A veterinarian.